Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AE
- Chemical substanceJ05AE09Tipranavir
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 2 registrations
Netherlands
CBG-MEB · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- J05AE09
- ATC group
- Anti-infectives for systemic use
- Registers
- 7
- Registrations
- 10
- With their own page
- 7
- Companies
- 4
All medicines with Tipranavir
Human medicines from every register that match Tipranavir by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
10 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Aptivus | United States | 250MG | capsule | Marketed | Boehringer Ingelheim |
| Aptivus | United States | 100MG/ML | solution | Marketed | Boehringer Ingelheim |
| Aptivus | European Union | Authorised | Boehringer Ingelheim International GmbH | ||
| Aptivus 100 mg/ml, drank | Netherlands | Drank | Authorised | Boehringer Ingelheim International GmbH | |
| Aptivus 250 MG Capsulas Blandas | Spain | 250 mg | cápsula blanda | Authorised | Boehringer Ingelheim International Gmbh |
| Aptivus 250 mg zachte capsules, zachte capsules | Netherlands | Capsule, zacht | Authorised | Boehringer Ingelheim International GmbH | |
| Aptivus | Croatia | Authorised | |||
| Aptivus 100 MG/ML Solucion Oral | Spain | 100 mg | solución oral | Withdrawn | Boehringer Ingelheim International Gmbh |
| Aptivus | Canada | 250 MG | Capsule | Cancelled | Boehringer Ingelheim (Canada) LTD Ltee |
| Elodius | Brazil | Cancelled | Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. |